phoxillum b22k4/0

Generic: magnesium chloride, sodium chloride, sodium bicarbonate, potassium chloride, and sodium phosphate dibasic dihydrate

Labeler: vantive us healthcare llc
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name phoxillum b22k4/0
Generic Name magnesium chloride, sodium chloride, sodium bicarbonate, potassium chloride, and sodium phosphate dibasic dihydrate
Labeler vantive us healthcare llc
Dosage Form INJECTION
Routes
INTRAVENOUS
Active Ingredients

magnesium chloride 3.05 g/L, potassium chloride .314 g/L, sodium bicarbonate 2.21 g/L, sodium chloride 6.95 g/L, sodium phosphate, dibasic .187 g/L

Manufacturer
Vantive US Healthcare LLC

Identifiers & Regulatory

Product NDC 24571-117
Product ID 24571-117_37da3e2a-3a1a-1784-e063-6394a90a969f
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA207026
Listing Expiration 2026-12-31
Marketing Start 2015-01-13

Pharmacologic Class

Classes
calculi dissolution agent [epc] increased large intestinal motility [pe] inhibition large intestine fluid/electrolyte absorption [pe] inhibition small intestine fluid/electrolyte absorption [pe] magnesium ion exchange activity [moa] osmotic activity [moa] osmotic laxative [epc] potassium compounds [cs] potassium salt [epc] stimulation large intestine fluid/electrolyte secretion [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 24571117
Hyphenated Format 24571-117

Supplemental Identifiers

UNII
M4I0D6VV5M GR686LBA74 660YQ98I10 451W47IQ8X 5SL0G7R0OK 02F3473H9O 8MDF5V39QO 33X04XA5AT

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name phoxillum b22k4/0 (source: ndc)
Generic Name magnesium chloride, sodium chloride, sodium bicarbonate, potassium chloride, and sodium phosphate dibasic dihydrate (source: ndc)
Application Number NDA207026 (source: ndc)
Routes
INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • 3.05 g/L
  • .314 g/L
  • 2.21 g/L
  • 6.95 g/L
  • .187 g/L
source: ndc
Packaging
  • 2 BAG in 1 CASE (24571-117-06) / 5 L in 1 BAG
source: ndc

Packages (1)

24571-117-06 2 BAG in 1 CASE (24571-117-06) / 5 L in 1 BAG

Ingredients (5)

magnesium chloride (3.05 g/L) potassium chloride (.314 g/L) sodium bicarbonate (2.21 g/L) sodium chloride (6.95 g/L) sodium phosphate, dibasic (.187 g/L)

Linked Drug Pages (1)

PRISMASOL BGK2/0, PRISMASOL BGK2/3.5, PRISMASOL BGK4/2.5, PRISMASOL BGK0/2.5, PRISMASOL B22GK4/0, PRISMASOL BK0/0/1.2, PRISMASOL BGK4/0/1.2, PHOXILLUM BK4/2.5, PHOXILLUM B22K4/0 ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "37da3e2a-3a1a-1784-e063-6394a90a969f", "openfda": {"unii": ["M4I0D6VV5M", "GR686LBA74", "660YQ98I10", "451W47IQ8X", "5SL0G7R0OK", "02F3473H9O", "8MDF5V39QO", "33X04XA5AT"], "spl_set_id": ["7f675fee-8940-4ece-bb0c-75ac79d8708c"], "manufacturer_name": ["Vantive US Healthcare LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "2 BAG in 1 CASE (24571-117-06)  / 5 L in 1 BAG", "package_ndc": "24571-117-06", "marketing_start_date": "20150113"}], "brand_name": "PHOXILLUM B22K4/0", "product_id": "24571-117_37da3e2a-3a1a-1784-e063-6394a90a969f", "dosage_form": "INJECTION", "pharm_class": ["Calculi Dissolution Agent [EPC]", "Increased Large Intestinal Motility [PE]", "Increased Large Intestinal Motility [PE]", "Increased Large Intestinal Motility [PE]", "Increased Large Intestinal Motility [PE]", "Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]", "Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]", "Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]", "Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]", "Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]", "Magnesium Ion Exchange Activity [MoA]", "Osmotic Activity [MoA]", "Osmotic Activity [MoA]", "Osmotic Activity [MoA]", "Osmotic Activity [MoA]", "Osmotic Laxative [EPC]", "Osmotic Laxative [EPC]", "Osmotic Laxative [EPC]", "Osmotic Laxative [EPC]", "Potassium Compounds [CS]", "Potassium Salt [EPC]", "Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]"], "product_ndc": "24571-117", "generic_name": "magnesium chloride, sodium chloride, sodium bicarbonate, potassium chloride, and sodium phosphate dibasic dihydrate", "labeler_name": "Vantive US Healthcare LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "PHOXILLUM", "brand_name_suffix": "B22K4/0", "active_ingredients": [{"name": "MAGNESIUM CHLORIDE", "strength": "3.05 g/L"}, {"name": "POTASSIUM CHLORIDE", "strength": ".314 g/L"}, {"name": "SODIUM BICARBONATE", "strength": "2.21 g/L"}, {"name": "SODIUM CHLORIDE", "strength": "6.95 g/L"}, {"name": "SODIUM PHOSPHATE, DIBASIC", "strength": ".187 g/L"}], "application_number": "NDA207026", "marketing_category": "NDA", "marketing_start_date": "20150113", "listing_expiration_date": "20261231"}